|
(Health-NewsWire.Net, July 30, 2015 ) The analysts forecast global ophthalmic therapeutic market to grow at a CAGR of 6.53% over the period 2014-2019.
Ophthalmology is the science of eyes. It is the branch of medicine concerned with the treatment of eye-related diseases and eye defects. Some of the common eye disorders are glaucoma, retinal diseases, conjunctivitis, refractive errors, color blindness, and retinitis. Many of the eye diseases do not show symptoms at early stages. They will be painless with no defect in vision until the disease progresses to an advanced stage. Regular eye checkups must be done to detect the development of any disorder. Proper care and hygiene must be ensured to protect the eyes.
Covered in this Report
The report covers the present scenario and the growth prospects of the global ophthalmic therapeutic market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various branded therapies, OTC drugs, and generics along with the drugs used as off-label for the treatment of ophthalmic disorders such as:
Glaucoma
Dry eye syndrome
Retinal disorders such as diabetic retinopathy, macular edema, RVO, and AMD
The report, Global Ophthalmic Therapeutic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of global ophthalmic therapeutic market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Purchase a Report Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=396147 .
Key Regions
Americas
APAC
EMEA
Key Vendors
Actavis
Bayer
F. Hoffmann-La Roche
Merck
Novartis
Pfizer
Regeneron Pharmaceuticals
Other Prominent Vendors
Acadia Pharmaceuticals
AC Immune
Acorn Biomedical
Acucela
Advanced Cell Technology
Aerie Pharmaceuticals
Alcon
Alexion Pharmaceuticals
Alimera Sciences
Allergan
Ampio Pharmaceuticals
Antisense Therapeutics
Avalanche Biotechnologies
BCN Peptides
Boehringer Ingelheim
Bristol-Myers Squibb
Carl Zeiss Meditec
Eleven Biotherapeutics
Falcon Pharmaceuticals
Gilead Sciences
GlaxoSmithKline
Glycadia
Icon Bioscience
iCo Therapeutics
Inotek Pharmaceuticals
Intellect Neurosciences
Isis Pharmaceuticals
Kowa Group
Laboratorios Sophia
Lexicon Pharmaceuticals
Lpath
Neurotech Pharma
NicOx
Numoda Capital
OPKO Health
Ophthotech Corporation
Ohr Pharmaceutical
Otsuka Pharmaceutical
PanOptica
Parexel International
Promedior
pSivida
Quark Pharmaceuticals
R-Tech Ueno
Santen Pharmaceutical
Seikagaku
Senju Pharmaceutical
Shire
SIFI
Sirnaomics
StemCells
ThromboGenics
Valeant Pharmaceuticals
Inquire before Buying at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=396147 .
Market Driver
Increase in Prevalence of Eye Diseases
Market Challenge
Lack of Awareness
Market Trend
Strategic Alliances
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=396147 .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
